MOM – Máster en Oncología Molecular

Faculty from Harvard, MD Anderson,
CSIC, Vall d’Hebrón, among others.

Recommended by the European School of Oncology
with scientific support of SEOM and SEHH.

Faculty from Harvard, CNIO, MD Anderson, CSIC, Vall d’Hebrón, among others

Faculty from Harvard, MD Anderson, CSIC, Vall d’Hebrón, among others

1 year Online Programme

Unique initiative in Europe

Recommended by the European School of Oncology with scientific support of SEOM and SEHH

INTRODUCTION AND GOALS

The Molecular Oncology Master – MOM, is a training program for clinical oncologists, pathologists, hematologists and other medical specialists or biomedical graduated students from fields associated with tumor disease.

The MOM is a unique initiative in the world, with more than 100 exceptional professors carefully selected at national and international level. Among MOM’s faculty are the higher exponents of molecular oncology discoveries and the authors of the content they teach.

The MOM program is offered by the Centro de Estudios Biosanitarios (CEB) (Biosciences Studies Centre) and has the recommendation of the European School of Oncology. It also has the scientific support of the Spanish Society of Medical Oncology (SEOM) and Spanish Society of Hematology and Hemotherapy (SEHH).

The MOM provides training in Molecular Oncology based on a multidisciplinary approach of tumor disease, which has a positive effect in care intervention.
The student will have access to basic knowledge about the origin and development of cancers, the methodology of basic research and clinical oncology, known patterns of phenotypic expression of tumors as well as other therapeutic approaches based on molecular pathways involved in carcinogenesis .

With this program you will receive a cutting-edge training for oncology specialists in the twenty-first century. Nowadays, a clinical practice of excellence cannot be conceived without a profound knowledge of the molecular basis of the disease and without a proper diagnosis, prognosis and treatment based on each patient molecular markers.

Name* Surname* Email* Phone* Speciality* Country* Accept privacy policy

More information ▼

I would like to receive information about the courses offered by the Centro de estudios biosanitarios, and can unsubscribe at any time.

Why doing a Molecular Oncology Master?

FORMACIÓN AVANZADA

ADVANCED TRAINING

The training received by specialists linked to the oncological disease during the Bachelor of Medicine and subsequent specialization, does not delve deeper and in detail on the knowledge of the molecular basis of cancer. Today, a clinical practice of excellence cannot be conceived without the knowledge of the molecular basis of the disease.

FORMACIÓN AVANZADA

LEADING CLINICAL PRACTICE

Diagnosis, prognosis and treatment based on the molecular pattern of the patient allows cutting-edge clinical practice. New therapeutic strategies are based on specific molecular targets inhibitors, or in blocking or activating certain routes. It is imperative a specialized training that allows professionals to deepen in the molecular basis of cancer and at the same time patients benefit from this knowledge.

FORMACIÓN AVANZADA

ADVANCES IN RESEARCH

Oncology from XXIst century is based on the progress of investigation. Only a joint translational research effort can bring these advances to patients. Research and training are essential tools to address cancer in daily clinical practice. Both approaches are needed for a correct patient treatment.

PROGRAM

Structure

Credits: 60 ECTS
Content distribution:
- Molecular Basis of cancer
- Proto-oncogenes and oncogenes
- Tumor supressor genes
- Cellular processes involved in carcinogenesis
- Molecular Pathology techniques
- Molecular Pathology in the clinic of solid tumors
- Molecular Pathology in the clinic of hematological tumors
- Methodology in clinical research in Oncology
- Risk factors in neoplasias
- Pharmacology and anti-tumor agents
- New molecular therapies
Download the full program

Modality

The MOM is taught online.

The student will access to recorded classes through the CEB e-learning platform.

Teacher’s power point presentation will be available to students for download.

Students can send queries to teachers from the e-learning platform.

Duration

12 months

Starting Next September 2020

Degree

Molecular Oncology Master
Private and not official degree awarded by the Centro de Estudios Biosanitarios.

DIRECTORS

MÓNICA LÓPEZ BARAHONA, PhD

GENERAL ACADEMIC DIRECTOR

PhD in Biochemistry
General Academic Director of CEB.

ALBERTO MUÑOZ TEROL, PhD

DIRECTOR OF MODULE I

PhD in Life Sciences.
Research Professor at C.S.I.C.

MIGUEL ÁNGEL PIRIS PINILLA MD, PhD

DIRECTOR OF MODULE II

MD and PhD in Medicine (Pathology)
Head of the Pathology Division at Hospital Universitario Fundación Jiménez Díaz, Madrid.

FÉLIX BONILLA VELASCO MD, PhD

DIRECTOR OF MODULE III

MD and PhD in Medicine (Internal Medicine and Oncology)

FERNANDO PELÁEZ PÉREZ, PhD

COORDINATOR OF PRACTICUM

PhD in Life Sciences.
Director of Biotechnology Program at Centro Nacional de Investigaciones Oncológicas (CNIO).

FACULTY

The faculty includes international recognised researchers and oncologists from institutions such Hasrvard-Beth Israel Deaconess Medical Center, MD Anderson Cancer Center, CSIC, Vall d’Hebron Institut de Recerca, among other.

> See full list of faculty.

MODULES

modulo_1

MODULE I

CELLULAR AND MOLECULAR BIOLOGY OF CANCER
(September 2019 – December 2019)

This module will cover the basic knowledge of cell biology and mechanisms flag of gene regulation, and changes caused by malignant transformation.

Molecular Processes will be reviewed, including genes controlling cell proliferation and biological activity of the main proto-oncogenes and tumor suppressor genes and the Implications of tampering. Also study the importance of the repair of genetic damage and mutator route in carcinogenesis, the basis of the processes of apoptosis, cellular senescence and immortalization, stem cells, angiogenesis and lymphangiogenesis and tumor immunology.

Main subjects:
1. Cell, genes, and regulation of gene expression .
2. Proto-oncogenes and oncogenes.
3. Tumor suppressors genes .
4. Cellular Processes involved in Carcinogenesis .

MODULE II

MOLECULAR PATHOLOGY
(January 2020 – March 2020)

Understanding through didactic presentations and optional laboratory work, basic aspects of molecular diagnostics, the technical and conceptual basis, its implementation…

…in clinical practice in selected diseases.
After completion of the module, the student must be able to:
Understand the basic vocabulary and concepts of molecular diagnostics;
Understand the conceptual foundations of the main techniques, their limitations and applications;
Interpret results of these techniques;
Interpret and evaluate scientific publications based on studies of molecular pathology;
Identify key areas of pathology where these techniques can be of practical use.

Main subjects:
1. Immunohistochemistry.
2. Cytogenetics.
3. Cancer genome.
4. Gene expression regulation and analysis. Transcriptomics. MiRNAS.
5. Proteomics.
6. Epigenetics.

MODULE III

MOLECULAR ONCOLOGY
(April 2020 – June 2020)

This module contains aspects of epidemiology, carcinogenesis and inheritance and analyzes the knowledge about new updated review of the possibilities of different approaches to…

…the design of drugs, the current state of drug search directed against molecular targets. We will review the various forms of immune therapy and gene therapy, and discuss the clinical trial methodology and application of molecular targets in addition to diagnosis and prognosis, problems and prospects in this field.

Main subjects:
1. Epidemiology and agents related to cancer risk.
2. FamilyCancer.
3. Pharmacology and antitumoral agents .
4. More treatment strategies .
5. Clinical research methodology.

MODULE IV

RESEARCH PROJECT

Students will perform a research project which may consist of conducting a research project developed in laboratories and / or hospitals, or in a literature review on a topic of antitumor therapies allowing interest in…

…Molecular Oncology, or in designing a research project. During the months assigned to carry out the research project the student will have a tutor. It is essential to have the approval of the tutor for the research work can be evaluated.

FORMACIÓN AVANZADA

ACADEMIC PROGRAM

See full program.

EVALUATION

At the end of each of the three theoretical modules, students perform a multiple choice test exam through the e-learning platform.

It is mandatory to approve the three tests independently to obtain the degree of Molecular Oncology Master. Passing the three exams, the arithmetic mean of the scores will account for 70% of the final grade. The remaining 30% will be the mark obtained in the research report that the student must perform.

REQUIREMENTS AND ADMISSION

Addressed to

Specialists in Oncology
Specialists in Pathology
Specialists in Hematology
Specialists in Radiotherapy
Other Graduates or Doctors in Biosciences areas with an interest in tumor disease

SELECTION AND DEADLINES

Candidates must hold a bachelor’s degree in a biomedical area.
You need to send your updated CV, in order to be evaluated by the Academic Board before for admission in the program.
A high level of English is required to attend the master’s program.

ADMISSION

Send your CV to:
egalian@ceb.edu.es

COSTS AND FINANCING

COSTS

Total cost is 6.900 € paid in 3 instalments:
First instalment 2.300€: before June 20th.
Second instalment 2.300€: before July 20th.
Third instalment 2.300€: before September 15th.

12-Month financing available without surcharge.

Payments are not refundable.

SCHOLARSHIPS

FINANCIAL AID
Scholarships for Academic Excellence
Currently we are calling for scholarships (partial) for the September 2022 intake for MOM in English.

You must send your data from HERE

Deadline: May 13, 2022

See RULES of the call

REQUEST FOR ADDITIONAL INFORMATION

If you want more information fill in your details here:

Name* Last name* E-mail* Phone* Specialty* Country* Comments Accept privacy policy

More information ▼

I want to receive information about the courses offered by CEB, I can unsubscribe whenever I want.

LASTEST NEWS

A NOVEL THERAPY FOR METASTATIC BREAST CANCER

29 March, 2022

MARIANO BARBACID RECEIVES THE INVESTITURE AS DOCTOR HONORIS CAUSA BY THE UNED

25 February, 2022

METPlatform: A SUPERFAST NEW METHOD TO TEST MULTIPLE DRUG COMBINATIONS ON PATIENTS BRAIN METASTASIS THAT CAN SIGNIFICANTLY IMPROVE SURVIVORSHIP

25 February, 2022

INTRODUCTION AND GOALS

NEWSLETTER

Why doing a Molecular Oncology Master?

PROGRAM

DIRECTORS

MÓNICA LÓPEZ BARAHONA, PhD

ALBERTO MUÑOZ TEROL, PhD

MIGUEL ÁNGEL PIRIS PINILLA MD, PhD

FÉLIX BONILLA VELASCO MD, PhD

FERNANDO PELÁEZ PÉREZ, PhD

FACULTY

MODULES

MODULE I

MODULE II

MODULE III

MODULE IV

REQUIREMENTS AND ADMISSION

Addressed to

SELECTION AND DEADLINES

ADMISSION

COSTS AND FINANCING

COSTS

SCHOLARSHIPS

REQUEST FOR ADDITIONAL INFORMATION

LASTEST NEWS

A NOVEL THERAPY FOR METASTATIC BREAST CANCER

MARIANO BARBACID RECEIVES THE INVESTITURE AS DOCTOR HONORIS CAUSA BY THE UNED

METPlatform: A SUPERFAST NEW METHOD TO TEST MULTIPLE DRUG COMBINATIONS ON PATIENTS BRAIN METASTASIS THAT CAN SIGNIFICANTLY IMPROVE SURVIVORSHIP

LATEST NEWS

FOLLOW US

CONTACT

Información